Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-06-054607
Filing Date
2006-10-12
Accepted
2006-10-12 18:27:49
Documents
1
Period of Report
2006-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3052
  Complete submission text file 0001209191-06-054607.txt   5079
Mailing Address 345 VASSAR STREET CAMBRIDGE MA 02139
Business Address 345 VASSAR STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENAERA CORP 5110 CAMPUS DRIVE PLYMOUTH MEETING PA 19462
Business Address C/O GENAERA CORP 5110 CAMPUS DR PLYMOUTH MEETING PA 19462 610 941 4020
WYNGAARDEN JAMES B (Reporting) CIK: 0001022940 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 061142969